M.Pharm in Pharmaceutical Sciences with First class. NET, GATE, GPAT qualified candidates with research experience and publications in peer- reviewed journals will be preferred.
M.Sc, M. Tech in Life Science or equivalent with at least 4 years hands on research experience in bioinformatic analysis of genomic, met agenomic data or Ph.D. in Life Science or equivalent with expertise in bioinformatic s of genomic, met agenomic data
M.Sc Life Sciences, Biotechnology or in allied Subjects. Fluorescent Sensors for the detection of citrulline in the plasma of patients with celiac disease and other enteropathies Aiding biopsy free diagnosis and follow-up monitoring of the disease: Molecular Design and Synthesis of Chemoselective Glyoxal Probes
Master Degree or PG Diploma in Life Sciences or Biomedical Sciences or Pharmacy or Public Health or Clinical Research.
at least 4 years of demonstrated experience in clinical trial monitoring or clinical site management experience.
Doctoral Degree in Science from a recognised university or equivalent in stem cell biology, developmental biology, pharmacology, and or maternal or child health.
The candidate must have a M.S, M.Pharm, degree in Medicinal chemistry, Natural Products, Pharmaceutical Analysis from a PCI, AICTE, UGC, NAAC recognized, accredited University, Central Autonomous Institutes with 60% marks or above.
M.Pharma, Masters in any biological sciences and life sciences with prior experience in handling laboratory mice or rats with experience in molecular biology techniques is desirable. Experience in molecular biology techniques such as PCR, DNA/RNA extraction, gel electrophoresis, genotyping
Master Degree in Pharmaceutical Sciences First-class with GPAT qualification Preferably in Pharmaceutics from a recognized University. developing nanoformulations, mammalian cell cultures, and in vivo experiments. Synthesis of Polymers, peptides Characterization of physicochemical Parameter, Determination of anticancer therapeutic effect in the in vitro assay systems, Validation of the in vitro results in the in vivo animal models of tumor-bearing mice model and infectious disease models